Skip to main content
PEN
NYSE Industrial Applications And Services

Penumbra Inc. to be Acquired by Boston Scientific in Definitive Agreement

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
10
Price
$354.5
Mkt Cap
$13.907B
52W Low
$221.26
52W High
$355.47
52W Position info
60% above low
Off High info
at 52W high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

PEN sits 60% above its 52-week low of $221.26.

Summary

Penumbra Inc. announced a definitive agreement to be acquired by Boston Scientific Corporation, marking a significant strategic move in the medical device sector.


Key Events · M&A and Partnerships · PEN

  • Definitive Acquisition Agreement

    Boston Scientific Corporation has entered into a definitive agreement to acquire Penumbra Inc., a leader in mechanical thrombectomy and neurovascular therapies.

  • Strategic Market Expansion

    The acquisition is expected to allow Boston Scientific to enter new, fast-growing segments within the vascular space, leveraging Penumbra's comprehensive product portfolio.


Analysis · PEN · Industrial Applications And Services

This filing confirms a definitive agreement for Boston Scientific Corporation to acquire Penumbra Inc. This is a transformative event for Penumbra, fundamentally altering its ownership and future trajectory. The acquisition validates Penumbra's position as a leading innovator in mechanical thrombectomy and neurovascular therapies, and typically results in a significant premium for shareholders. For Boston Scientific, it represents a strategic expansion into high-growth segments within the vascular space. The stock is currently trading near its 52-week high, suggesting the market has already reacted positively to the news or anticipated such a development.

At the time of this filing, PEN was trading at $354.50 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $13.9B. The 52-week trading range was $221.26 to $355.47. This filing was assessed with positive market sentiment and an importance score of 10 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PEN - Latest Insights

PEN
Nov 02, 2026, 6:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $321.99
Real-time Price: $319.12 info
Change: -$2.87 (-0.89%) info
Market Cap: $12.578B info
PEN
Oct 29, 2026, 4:05 PM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $321.97
Real-time Price: $319.12 info
Change: -$2.85 (-0.89%) info
Market Cap: $12.578B info
PEN
Oct 20, 2026, 9:00 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $321.73
Real-time Price: $319.12 info
Change: -$2.61 (-0.81%) info
Market Cap: $12.578B info
PEN
Jul 30, 2026, 4:44 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $319.83
Real-time Price: $319.12 info
Change: -$0.710 (-0.22%) info
Market Cap: $12.578B info
PEN
Jul 30, 2026, 4:14 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $319.83
Real-time Price: $319.12 info
Change: -$0.710 (-0.22%) info
Market Cap: $12.578B info